Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000893838-06-000046
Filing Date
2006-05-03
Accepted
2006-05-03 20:54:04
Documents
2
Period of Report
2006-05-01

Document Format Files

Seq Description Document Type Size
1 rexform3cheong_ex.html 3  
1 rexform3cheong_ex.xml 3 1650
2 POWER OF ATTORNEY rexpoacheong.txt EX-24 3209
  Complete submission text file 0000893838-06-000046.txt   6781
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address REXAHN PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 240-268-5300
Cheong Kwang Soo (Reporting) CIK: 0001361686 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50590 | Film No.: 06805761